Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer
- PMID: 16451736
- PMCID: PMC1373659
- DOI: 10.1186/1471-2407-6-31
Combined immunohistochemistry of beta-catenin, cytokeratin 7, and cytokeratin 20 is useful in discriminating primary lung adenocarcinomas from metastatic colorectal cancer
Abstract
Background: It is important to discriminate between primary and secondary lung cancer. However, often, the discriminating diagnosis of primary lung acinar adenocarcinoma and lung metastasis of colorectal cancer based on morphological and pathological findings is difficult. The purpose of this study was to evaluate the clinical usefulness of immunohistochemistry of beta-catenin, cytokeratin (CK) 7, and CK20 for the discriminating diagnosis of lung cancer.
Methods: We performed immunohistochemistry of beta-catenin, CK7, and CK20 in 19 lung metastasis of colorectal cancer samples, 10 corresponding primary colorectal cancer samples and 11 primary lung acinar adenocarcinoma samples and compared the levels of accuracy of the discriminating diagnosis by using antibodies against these antigens.
Results: Positive staining of beta-catenin was observed in all the lung metastasis of colorectal cancer samples as well as in the primary colorectal cancer samples but in none of the primary lung acinar adenocarcinoma samples. Positive staining of CK7 was observed in 90.9% of the primary lung acinar adenocarcinoma samples and in 5.3% of the lung metastasis of colorectal cancer samples, but in none of the primary colorectal cancer samples. Positive staining of CK20 was observed in all the primary colorectal cancer samples and in 84.2% of the lung metastasis of colorectal cancer samples, but in none of the primary lung acinar adenocarcinoma samples.
Conclusion: Combined immunohistochemistry of beta-catenin, CK7, and CK20 is useful for making a discriminating diagnosis between lung metastasis of colorectal cancer and primary lung acinar adenocarcinoma. This method will enable accurate diagnosis of a lung tumor and will be useful for selecting appropriate therapeutic strategies, including chemotherapeutic agents and operation methods.
Figures

Similar articles
-
Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.Am J Clin Pathol. 2004 Sep;122(3):421-7. doi: 10.1309/UMF7-15KR-G2V1-98YD. Am J Clin Pathol. 2004. PMID: 15362373
-
Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors.Cancer. 1999 Jan 1;85(1):171-7. doi: 10.1002/(SICI)1097-0142(19990101)85:1<171::AID-CNCR24>3.0.CO;2-V. Cancer. 1999. PMID: 9921990
-
[Use of thyroid transcription factor-1, surfacfant protein-B, cytokeratin 7 and cytokeratin 20 in discrimination between primary and metastatic adenocarcinoma of lung].Zhonghua Yi Xue Za Zhi. 2003 Aug 10;83(15):1350-2. Zhonghua Yi Xue Za Zhi. 2003. PMID: 12930693 Chinese.
-
Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features.Histopathology. 2005 Sep;47(3):231-47. doi: 10.1111/j.1365-2559.2005.02194.x. Histopathology. 2005. PMID: 16115224 Review.
-
Immunohistochemistry as a tool in the differential diagnosis of ovarian tumors: an update.Int J Gynecol Pathol. 2005 Jan;24(1):39-55. Int J Gynecol Pathol. 2005. PMID: 15626916 Review.
Cited by
-
The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody.Diagn Pathol. 2012 Jan 23;7:9. doi: 10.1186/1746-1596-7-9. Diagn Pathol. 2012. PMID: 22268990 Free PMC article.
-
Clinical relevance associated to the analysis of circulating tumour cells in patients with solid tumours.Clin Transl Oncol. 2009 Oct;11(10):659-68. doi: 10.1007/s12094-009-0421-z. Clin Transl Oncol. 2009. PMID: 19828408 Review.
-
An unusual case of aortic metastasis from lung cancer.Discoveries (Craiova). 2020 Mar 31;8(1):e106. doi: 10.15190/d.2020.3. Discoveries (Craiova). 2020. PMID: 32309623 Free PMC article.
-
Cell-Free RNA Content in Peripheral Blood as Potential Biomarkers for Detecting Circulating Tumor Cells in Non-Small Cell Lung Carcinoma.Int J Mol Sci. 2016 Nov 5;17(11):1845. doi: 10.3390/ijms17111845. Int J Mol Sci. 2016. PMID: 27827952 Free PMC article.
-
Isolated, disseminated and circulating tumour cells in prostate cancer.Nat Rev Urol. 2012 Aug;9(8):448-63. doi: 10.1038/nrurol.2012.136. Epub 2012 Jul 10. Nat Rev Urol. 2012. PMID: 22777287 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous